Is CEL SCI Stock a Good Investment?
CEL SCI Investment Advice | CVM |
- Examine CEL SCI's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research CEL SCI's leadership team and their track record. Good management can help CEL SCI navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact CEL SCI's business and its evolving consumer preferences.
- Compare CEL SCI's performance and market position to its competitors. Analyze how CEL SCI is positioned in terms of product offerings, innovation, and market share.
- Check if CEL SCI pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about CEL SCI's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in CEL SCI Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if CEL SCI Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine CEL SCI Stock
Researching CEL SCI's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.52. CEL SCI Corp last dividend was issued on the 28th of August 1996. The entity had 1:25 split on the 15th of June 2017.
To determine if CEL SCI is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CEL SCI's research are outlined below:
| CEL SCI Corp generated a negative expected return over the last 90 days | |
| CEL SCI Corp has high historical volatility and very poor performance | |
| CEL SCI Corp has some characteristics of a very speculative penny stock | |
| CEL SCI Corp has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (32.19 M) with loss before taxes, overhead, and interest of (25.36 M). | |
| CEL SCI Corp has about 22.67 M in cash with (22.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| CEL SCI Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study |
CEL SCI uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CEL SCI Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CEL SCI's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact CEL SCI's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises CEL SCI's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-12 | 2023-03-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2023-08-10 | 2023-06-30 | -0.16 | -0.19 | -0.03 | 18 | ||
2023-02-14 | 2022-12-31 | -0.21 | -0.18 | 0.03 | 14 | ||
2022-08-12 | 2022-06-30 | -0.19 | -0.23 | -0.04 | 21 | ||
2019-12-16 | 2019-09-30 | -0.09 | -0.13 | -0.04 | 44 | ||
2022-05-16 | 2022-03-31 | -0.17 | -0.23 | -0.06 | 35 | ||
2021-02-12 | 2020-12-31 | -0.15 | -0.21 | -0.06 | 40 | ||
2021-12-22 | 2021-09-30 | -0.1 | -0.19 | -0.09 | 90 |
CEL SCI's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 44.71 M.Market Cap |
|
CEL SCI's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.96) | (1.01) | |
| Return On Capital Employed | (1.45) | (1.52) | |
| Return On Assets | (0.95) | (1.00) | |
| Return On Equity | (2.82) | (2.96) |
Determining CEL SCI's profitability involves analyzing its financial statements and using various financial metrics to determine if CEL SCI is a good buy. For example, gross profit margin measures CEL SCI's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CEL SCI's profitability and make more informed investment decisions.
Evaluate CEL SCI's management efficiency
CEL SCI Corp has Return on Asset of (0.6141) % which means that on every $100 spent on assets, it lost $0.6141. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.502) %, meaning that it generated no profit with money invested by stockholders. CEL SCI's management efficiency ratios could be used to measure how well CEL SCI manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of December 2024, Return On Tangible Assets is likely to drop to -1.01. In addition to that, Return On Capital Employed is likely to drop to -1.52. At this time, CEL SCI's Total Assets are very stable compared to the past year. As of the 16th of December 2024, Non Current Assets Total is likely to grow to about 28.5 M, while Return On Tangible Assets are likely to drop (1.01).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.34 | 0.32 | |
| Tangible Book Value Per Share | 0.34 | 0.32 | |
| Enterprise Value Over EBITDA | (2.12) | (2.23) | |
| Price Book Value Ratio | 3.79 | 3.60 | |
| Enterprise Value Multiple | (2.12) | (2.23) | |
| Price Fair Value | 3.79 | 3.60 | |
| Enterprise Value | 58.5 M | 82.9 M |
The leadership approach at CEL SCI's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.688 |
Basic technical analysis of CEL Stock
As of the 16th of December 2024, CEL SCI shows the Mean Deviation of 3.77, risk adjusted performance of (0.07), and Coefficient Of Variation of (886.48). CEL SCI Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CEL SCI Corp standard deviation and value at risk to decide if CEL SCI Corp is priced adequately, providing market reflects its regular price of 0.69 per share. As CEL SCI Corp is a penny stock we also strongly suggest to validate its jensen alpha numbers.CEL SCI's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CEL SCI insiders, such as employees or executives, is commonly permitted as long as it does not rely on CEL SCI's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CEL SCI insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CEL SCI's Outstanding Corporate Bonds
CEL SCI issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CEL SCI Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CEL bonds can be classified according to their maturity, which is the date when CEL SCI Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| CE 605 15 MAR 25 Corp BondUS15089QAL86 | View | |
| CE 6165 15 JUL 27 Corp BondUS15089QAM69 | View | |
| CE 14 05 AUG 26 Corp BondUS15089QAK04 | View | |
| CE 6379 15 JUL 32 Corp BondUS15089QAP90 | View | |
| CE 633 15 JUL 29 Corp BondUS15089QAN43 | View |
Understand CEL SCI's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing CEL SCI's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 0.9956 | |||
| Mean Deviation | 3.77 | |||
| Coefficient Of Variation | (886.48) | |||
| Standard Deviation | 5.95 | |||
| Variance | 35.35 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | 0.9856 | |||
| Maximum Drawdown | 28.0 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 8.2 | |||
| Skewness | 1.99 | |||
| Kurtosis | 8.1 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 0.9956 | |||
| Mean Deviation | 3.77 | |||
| Coefficient Of Variation | (886.48) | |||
| Standard Deviation | 5.95 | |||
| Variance | 35.35 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.42) | |||
| Treynor Ratio | 0.9856 | |||
| Maximum Drawdown | 28.0 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 8.2 | |||
| Skewness | 1.99 | |||
| Kurtosis | 8.1 |
Consider CEL SCI's intraday indicators
CEL SCI intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CEL SCI stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CEL SCI time-series forecasting models is one of many CEL SCI's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CEL SCI's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
CEL Stock media impact
Far too much social signal, news, headlines, and media speculation about CEL SCI that are available to investors today. That information is available publicly through CEL media outlets and privately through word of mouth or via CEL internal channels. However, regardless of the origin, that massive amount of CEL data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CEL SCI news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CEL SCI relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CEL SCI's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CEL SCI alpha.
When determining whether CEL SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.61) | Return On Equity (2.50) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between CEL SCI's value and its price, as these two are different measures arrived at by various means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.